NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: The 2016 Cotzias Lecture.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 27920282)

Published in Neurology on December 06, 2016

Authors

Josep Dalmau1

Author Affiliations

1: From the Service of Neurology, Hospital Clinic-IDIBAPS, University of Barcelona; Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Spain; and Department of Neurology, University of Pennsylvania, Philadelphia. Jdalmau@clinic.ub.es.

Articles cited by this

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol (2008) 21.53

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol (2007) 16.81

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol (2013) 11.47

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 8.88

Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry (1991) 8.10

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain (2010) 6.84

Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain (2005) 6.81

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci (2010) 6.44

Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol (2005) 5.89

Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol (2009) 5.75

Paraneoplastic syndromes involving the nervous system. N Engl J Med (2003) 5.46

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci (2008) 5.12

AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol (2009) 4.49

EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell (2000) 4.34

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol (2013) 4.18

Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol Today (1993) 3.81

Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology (2010) 3.40

Neuronal autoantigens--pathogenesis, associated disorders and antibody testing. Nat Rev Neurol (2012) 3.20

Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol (2012) 3.12

Long-term dynamics of CA1 hippocampal place codes. Nat Neurosci (2013) 3.06

Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol (2011) 2.99

A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol (2016) 2.86

From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology (2011) 2.70

Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology (2011) 2.57

Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol (2014) 2.53

Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain (2012) 2.39

Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology (2011) 2.32

Abolition of long-term stability of new hippocampal place cell maps by NMDA receptor blockade. Science (1998) 2.25

Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain (2012) 2.17

Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis. JAMA Neurol (2013) 2.12

Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol (2014) 2.07

Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities. Neurology (2003) 2.03

The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron (2001) 2.02

Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients. Neurology (2015) 1.96

Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology (2015) 1.83

Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med (2000) 1.76

Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol (2014) 1.73

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain (2014) 1.67

Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. Brain (2014) 1.59

Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability. Biol Psychiatry (2014) 1.55

Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci (2013) 1.48

Burden of encephalitis-associated hospitalizations in the United States, 1998-2010. Neurology (2014) 1.47

Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med (1982) 1.45

Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor. Mov Disord (2013) 1.43

Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition. Brain (2015) 1.39

In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. Orphanet J Rare Dis (2010) 1.33

Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol (2015) 1.13

Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties. Mol Psychiatry (2013) 1.12

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery. Mol Psychiatry (2013) 1.05

Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis. J Neurosci (2014) 1.04

Late-onset anti-NMDA receptor encephalitis. Neurology (2013) 1.01

The clinical spectrum of Caspr2 antibody-associated disease. Neurology (2016) 0.97

Human neurexin-3α antibodies associate with encephalitis and alter synapse development. Neurology (2016) 0.96

Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons. Neurology (2015) 0.93

Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome. J Neuroinflammation (2016) 0.91

Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis. Brain (2016) 0.90

Intrathecal injection of P/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice. J Neuroimmunol (2013) 0.90

Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity. Ann Neurol (2016) 0.88

Anti-N-methyl-D-aspartate receptor encephalitis: a patient with refractory illness after 25 months of intensive immunotherapy. JAMA Neurol (2013) 0.87

Choreoathetosis as an initial sign of relapsing of herpes simplex encephalitis. Pediatr Neurol (1994) 0.86

Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer. JAMA Neurol (2016) 0.86

NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis? Trends Neurosci (2016) 0.86

What is and what should always have been: long-lived plasma cells induced by T cell-independent antigens. J Immunol (2013) 0.81

Inhibitory axons are targeted in hippocampal cell culture by anti-Caspr2 autoantibodies associated with limbic encephalitis. Front Cell Neurosci (2015) 0.81

The role of thymomas in the development of myasthenia gravis. Ann N Y Acad Sci (2003) 0.81

Clinical reasoning: agitation and psychosis in a patient after renal transplantation. Neurology (2012) 0.78